Filing Flows › Cerenome (CNSY) › Q2 2026 › vs Q1 2026
Cerenome (CNSY) Q2 2026 vs Q1 2026 (quarter over quarter)
Cerenome's revenue fell $617K (-60%) from $1.0M in Q1 2026 to $411K in Q2 2026.
Cerenome, Q2 2026: revenue $411K (-70% year over year), net loss $9.0M, operating cash flow −$7.1M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $411K | $1.0M | −$617K | -60% |
| Other income, net | $51K | $173K | −$122K | -71% |
| Net loss | $9.0M | $6.9M | $2.1M | +30% |
| Costs & expenses | $9.5M | $8.1M | $1.3M | +16% |
| Operating costs | $9.5M | $8.1M | $1.3M | +16% |
| Research & development | $4.3M | $2.9M | $1.4M | +49% |
| General & admin | $5.2M | $5.3M | −$79K | -1% |
| Operating cash sources | $9.0M | $6.9M | $2.1M | +30% |
| Depreciation & amortization | $137K | $96K | $41K | +43% |
| Share-based compensation | $830K | $1.0M | −$192K | -19% |
| Working capital & other | $907K | −$410K | $1.3M | — |
| Cash used in operations | $7.1M | $6.2M | $894K | +14% |
| Net loss absorbed | $9.0M | $6.9M | $2.1M | +30% |
Questions
How much did Cerenome's revenue grow quarter over quarter in Q2 2026?
Cerenome's revenue fell $617K (-60%) from $1.0M in Q1 2026 to $411K in Q2 2026.